Affimed N.V. - Common Stock (NQ:AFMD)

0.1815 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Affimed N.V. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Affimed to Host Investor Event Highlighting AFM13 Clinical Development at 2022 ASH Annual Meeting

December 01, 2022

From Affimed N.V.

Via GlobeNewswire

Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday ↗

November 18, 2022

Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday.

Via Benzinga

Why Shares of Affimed Fell Thursday ↗

November 17, 2022

The clinical-stage biotech focuses on immuno-oncology therapies.

Via The Motley Fool

Recap: Affimed Q2 Earnings ↗

August 11, 2022

Affimed (NASDAQ:AFMD) reported its Q2 earnings results on Thursday, August 11, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

BrightView Holdings, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday ↗

November 17, 2022

U.S. stocks traded lower, with the Nasdaq dropping more than 100 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗

November 17, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Affimed: Q1 Earnings Insights ↗

June 01, 2022

Affimed (NASDAQ:AFMD) reported its Q1 earnings results on Wednesday, June 1, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗

November 16, 2022

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.

Via Benzinga

Lowe's, Alcon And Some Other Big Stocks Moving Higher On Wednesday ↗

November 16, 2022

U.S. stocks traded lower, with the Nasdaq dropping more than 180 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Affimed Reports Third Quarter 2022 Financial Results and Highlights Recent Clinical and Corporate Progress

November 15, 2022

From Affimed N.V.

Via GlobeNewswire

Earnings Scheduled For November 15, 2022 ↗

November 15, 2022

Companies Reporting Before The Bell • Alkaline Water Co (NASDAQ:WTER) is likely to report quarterly loss at $0.05 per share on revenue of $18.31 million.

Via Benzinga

Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday ↗

November 08, 2022

Gainers

Via Benzinga

Affimed Provides Data Update from Two Phase 1/2a Trials with its Innate Cell Engager AFM24 in Solid Tumor Patients at the 37th SITC Annual Meeting

November 07, 2022

From Affimed N.V.

Via GlobeNewswire

Why Oyster Point Pharma Shares Are Trading Higher By Around 40%? Here Are 49 Stocks Moving In Monday's Mid-Day Session ↗

November 07, 2022

Gainers Dragon Victory International Limited (NASDAQ: LYL) surged 52.2% to $0.6870.

Via Benzinga

Why Starbucks Shares Are Trading Higher; Here Are 43 Stocks Moving Premarket ↗

November 04, 2022

Gainers Sentage Holdings Inc. (NASDAQ: SNTG) shares rose 67.7% to $5.10 in pre-market trading after jumping 24% on Thursday.

Via Benzinga

Affimed to Report Third Quarter 2022 Financial Results & Corporate Update on November 15, 2022

November 04, 2022

From Affimed N.V.

Via GlobeNewswire

Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE®) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101

November 03, 2022

From Affimed N.V.

Via GlobeNewswire

Affimed Announces Presentation of Phase 1/2 Data from AFM13 in Combination with Allogeneic NK Cells and Preclinical AFM28 Data at ASH 2022 Annual Meeting

November 03, 2022

From Affimed N.V.

Via GlobeNewswire

Affimed to Present at the 2022 Jefferies London Healthcare Conference

November 01, 2022

From Affimed N.V.

Via GlobeNewswire

Why Affimed Stock Plummeted by Over 16% Today ↗

October 10, 2022

An analyst's downgrade brings out the bears for the European cancer treatment developer.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2022 ↗

October 10, 2022

Upgrades

Via Benzinga

Domino's Pizza To $375? Plus Stifel Cuts Price Target On This Stock By Around 78% ↗

October 10, 2022

Credit Suisse cut the price target on Domino's Pizza, Inc. (NYSE: DPZ) from $425 to $375. Domino's shares fell 0.3% to $313.70 in pre-market trading.

Via Benzinga

Affimed Announces Two Clinical Update Presentations on its Novel Bispecific Innate Cell Engager AFM24 at the 37th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

October 05, 2022

From Affimed N.V.

Via GlobeNewswire

Preview: Affimed's Earnings ↗

August 10, 2022

Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Thursday, 2022-08-11. Here's what investors need to know before the announcement. Analysts estimate that Affimed will...

Via Benzinga

7 Undervalued Biotech Stocks to Buy Before They Boom ↗

July 25, 2022

Despite recession fears, biological sciences will never go out of style, thus benefitting these undervalued biotech stocks to buy.

Via InvestorPlace

6 Blue-Chip Stocks to Sell Now ↗

July 18, 2022

This article is about 6 blue-chip stocks to sell now. They are severely overvalued or are likely to move down soon with a recession.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Monday ↗

June 06, 2022

Monday's session saw 84 companies set new 52-week lows.

Via Benzinga

Earnings Scheduled For June 1, 2022 ↗

June 01, 2022

Companies Reporting Before The Bell • Affimed (NASDAQ:AFMD) is projected to report quarterly loss at $0.19 per share on revenue of $10.05 million.

Via Benzinga

Earnings Preview: Affimed ↗

May 31, 2022

Affimed (NASDAQ:AFMD) is set to give its latest quarterly earnings report on Wednesday, 2022-06-01. Here's what investors need to know before the announcement. Analysts estimate that Affimed will...

Via Benzinga

The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More ↗

April 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.